OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-generation antigen-presenting cell immune therapeutics for gliomas
Catalina Lee-Chang, Maciej S. Lesniak
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 84

Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 63

Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 32

Engineering nanomaterials for glioblastoma nanovaccination
Fatima Hameedat, Bárbara B. Mendes, João Conniot, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 9, pp. 628-642
Closed Access | Times Cited: 13

Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 10

Autologous Nanovaccine Induces Immunogenic Domino Effect to Prevent Postoperative Recurrence of Orthotopic Glioblastoma
Jinghong Yang, Ke Zhang, Guangliang Zhang, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1

Vaccine-based immunotherapy and related preclinical models for glioma
Binghao Zhao, Longping Yao, Maryam Hatami, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 965-981
Open Access | Times Cited: 7

Designing Selenium Nanoadjuvant as Universal Agent for Live‐Killed Virus‐Based Vaccine
Bo Deng, Xiaoming He, Dongdong Wang, et al.
Small Methods (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 11

Biological function, regulatory mechanism, and clinical application of mannose in cancer
Haoyi Jin, Xi Liu, Hongxu Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188970-188970
Closed Access | Times Cited: 11

Supramolecular self-assembly of multifunctional carrageenan-based Nanomicelles for effective tumor therapy via apoptosis and immunogenic cell death
Xiangyan Chen, Guohua Ma, Junyao Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141518-141518
Closed Access

Effective extracellular vesicles in glioma: Focusing on effective ncRNA exosomes and immunotherapy methods for treatment
Sulieman Ibraheem Shelash Al‐Hawary, Sharif Alhajlah, Bokov Dmitry Olegovich, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 3

B cell-based therapy produces antibodies that inhibit glioblastoma growth
Si Wang, Brandyn Castro, Joshua L. Katz, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 3

NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
Madanraj Appiya Santharam, Akhil Shukla, Dominique Lévesque, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7206-7206
Open Access | Times Cited: 7

Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2

Local immunotherapy of glioblastoma: A comprehensive review of the concept
Mohammadmahdi Sabahi, Arash Salehipour, Mohammad Sajjad Yavari Bazl, et al.
Journal of Neuroimmunology (2023) Vol. 381, pp. 578146-578146
Closed Access | Times Cited: 4

Clinical analysis of the efficacy of radiation therapy for primary high-grade gliomas guided by biological rhythms
Zhanfeng Niu, Zhihua Yang, Shengyu Sun, et al.
Translational Oncology (2024) Vol. 45, pp. 101973-101973
Open Access | Times Cited: 1

Combination of tumor antigen drainage and immune activation to promote a cancer-immunity cycle against glioblastoma
Xu Han, Xiaomei Zhao, Jincai Luo
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Irina Larionova, Pavel Iamshchikov, Анна Казакова, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Recent advances in immunotherapy-involved combination cancer therapy based on ZIF-8
G H Wang, Lin Li, Jiapeng Wang, et al.
AIP Advances (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 1

Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond
Surya Pandey, Meghan E. Cholak, Rishita Yadali, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 475-475
Open Access

SMG9 is a novel prognostic-related biomarker in glioma correlating with ferroptosis and immune infiltrates
Yong Dai, Huan Zhang, Sujuan Feng, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25716-e25716
Open Access

Design and development of gemcitabine loaded chitosan cloaked polymeric nanoparticles: investigation of glioma cancer cytotoxicity and its apoptosis inductions
Xiatong Liu, Fengdong Yang, Zong Wang, et al.
Journal of Materials Science (2024) Vol. 59, Iss. 23, pp. 10388-10405
Closed Access

Combination of microparticles vaccine with MSI-1436 exerts a strong immune response for hepatocellular carcinoma
Zhan Zhao, Jiaqing Cheng, Fang Liu, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 3, pp. 565-578
Closed Access

Page 1 - Next Page

Scroll to top